The Brazil aesthetic equipment market enjoys a valuation of US$ 1.8 Billion in 2022 and it is further projected to expand at a CAGR of 15.5% over the forecast years. According to a recent study by Future Market Insights, non-energy based aesthetic device segment is leading the market with a share of about 88.4% in the year 2022, within the Brazil market.
Market Outlook
Data Points | Market Insights |
---|---|
Market Value 2022 | US$ 1.8 Billion |
Market Value 2033 | US$ 8.6 Billion |
CAGR 2023 to 2033 | 15.5% |
Market Share of Top 4 Key Players | 43.2% |
Key Market Players | AbbVie Inc., Alma Lasers, Cutera Inc., Silimed Indústria de Implantes Ltda., GC Aesthetics, Bausch & Lomb Incorporated, Hologic Inc., Boston Scientific (Lumenis Inc.), LUTRONIC, Syneron Medical Ltd., Venus Concept, Genesis Biosystems, Inc., POLYTECH Health & Aesthetics GmbH, Lifesil, Candela Corp., Cynosure Inc., Lumenis Ltd., Sientra Inc., Galderma Laboratories, Merz Pharma, Teoxane Laboratories, Suneva Medical, Anika Therapeutics |
Brazil aesthetic equipment are devices that combine healthcare and beauty services with lasers or other energy-based technologies and non-energy based technologies to improve a person's physical attractiveness. Aesthetic devices (especially implants) are also use to correct abnormalities caused by accidents, trauma and other congenital illnesses.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The Brazilian sales of the market are anticipated to rise at a CAGR of 15.5% between 2023 and 2033. The market is expanding as a result of rising skin disorders, increased use of minimally invasive and non-invasive aesthetic procedures and improved consumer awareness of beauty products.
The Brazilian market holds around 5.3% share of the overall dermatology market with a value of around US$ 33.7 Billion, in 2022.
Aesthetic medical device techniques can differ depending on the therapy and condition being treated. In medicated procedures, a variety of aesthetic devices are used. The most advanced aesthetic devices can also rejuvenate healthy skin on the face, giving customers a non-invasive option as well for facial rejuvenation, body contouring and cellulite reduction and breast augmentation.
The rate at which new devices are adopted by physicians and clinics is influenced by factors such as efficacy, safety, ease of use, cost and the availability of support. Manufacturers that can develop devices that meet these criteria and provide strong technical and marketing support are likely to see higher adoption rates.
The cosmetics industry has experienced rapid growth in Brazil due to factors such as increased disposable income, changing social norms and the rise of social media influencing general population. These factors are increasing demand for aesthetic procedures and devices. Manufacturers that can capitalize on this trend and offer innovative and effective devices are likely to see significant growth in the Brazilian market.
Owing to the above-mentioned factors, the Brazil market is expected to grow at a prominent pace and reach a valuation of around US$ 8.6 Billion during the year 2033.
The growing middle class population in Brazil is a significant driver for the Brazil aesthetic equipment market. As the middle class population in Brazil continues to grow, more people have access to disposable income, which has led to increased demand for aesthetic treatments.
The use of social media platforms to market aesthetic treatments has become a popular trend in Brazil. Celebrities and influencers in Brazil are also becoming more open about their aesthetic treatments, which has helped reduce the stigma surrounding these procedures. For example, in 2019, Brazilian singer Anitta spoke openly about her use of Botox and other aesthetic treatments, which helped increase awareness and acceptance of these treatments among the population.
The high cost of aesthetic treatments is a key restraint to the Brazil aesthetic equipment market. Aesthetic treatments such as cosmetic surgery, non-surgical procedures and other aesthetic medical devices can be expensive, making them prohibitively expensive for many patients.
The Brazil aesthetic equipment market is strictly regulated by the National Health Regulatory Agency (ANVISA). The regulatory environment is designed to ensure that medical devices are safe and effective, but it can also present challenges for industry players.
The lack of qualified professionals is another significant restraint for the Brazil aesthetic equipment market.
The South-east region dominates Brazil with a total market share of around 35.5% in the Brazilian market 2022. The Southeast region of Brazil has the high population density in the country, with a huge and expanding middle-class population driving up demand for aesthetic treatments. This region is economically more developed than any other region, with a well-established healthcare system and high levels of disposable income, high concentration of healthcare experts, well-developed medical device distribution network; and hence, boosting the market for cosmetic medical equipment.
South region holds a market share of 34.2% in the Brazilian market 2022. The South area of Brazil is one of the wealthiest regions which has raised demand for aesthetic treatments. The South has a high level of awareness regarding aesthetic treatments. The South region is an established tourist destination with many visitors interested in beauty treatments. As a result, the region now has a significant demand for cosmetic medical equipment. While not as large as in the Southeast, the South region's middle class is expanding, as is demand for aesthetic treatments and medical devices.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Non-energy based aesthetic devices held market share at about 88.4% in the Brazilian market 2022. As people become more aware of the risks and side effects associated with invasive cosmetic surgeries, the demand for non-invasive and minimally invasive procedures has grown significantly. Non-energy based aesthetic devices offer a safe and effective alternative to surgical procedures and an increase in the number of populations that are concerned with their appearance, driving the market growth. The botulinum toxin among other non-energy-based aesthetic device is growing more and is anticipated to continue growing during the forecast period. Cosmetic botulinum toxin injections can be used to reduce dynamic face wrinkles, rectify facial asymmetry and emphasize or correct gender-specific anatomic correlations.
Breast augmentation held market share at about 14.8% in the Brazilian market 2022. The Brazilian aesthetic equipment market for breast augmentation application is a significant contributor to the growth of the overall aesthetic medical devices market in Brazil.
Body and extremities held market share of about 44.6% in the Brazilian market in 2022. The Brazilian aesthetic equipment market is segmented into various applications, including skin tightening, body contouring, cellulite reduction, feminine rejuvenation, tattoos and pigmentation, acne and acne scars, vascular lesions and others. Non-invasive treatments such as CoolSculpting and SculpSure for the reduction of unwanted fat in the arms, legs and other areas of the body have gained popularity in recent years.
The social class B held market share at about 42.7% in the Brazilian market 2022. The expanding middle class in Brazil is driving the growth of the aesthetic equipment market. As the Brazilian economy continues to grow, the middle class is expanding and consumers have more disposable income to spend on aesthetic procedures and treatments. An ageing population, an increase in obesity and increased awareness of aesthetic procedures and the adoption of minimally invasive surgeries, is driving the market.
Dermatology and cosmetology clinics hold a market share of 35.8% in the Brazilian market 2022. Dermatology and cosmetology clinics play a significant role in driving the Brazilian aesthetic medical devices market. These clinics offer a variety of aesthetic procedures and treatments that require the use of medical devices, such as lasers, injectable and energy-based aesthetic devices, to enhance the appearance of the skin and body.
Dermatology and cosmetology clinics are important drivers of this growth as they provide a wide range of aesthetic procedures and treatments and they invest heavily in the latest technologies and medical devices to meet the demand of their patients. Therefore, it can be inferred that dermatology and cosmetology clinics in Brazil are playing a significant role in driving the growth of the aesthetic equipment market.
Strategic partnerships and collaborations are another key supply-side driver for the Brazil aesthetic equipment market. Manufacturers are entering into strategic partnerships and collaborations to improve their supply chain and distribution channels, expand their reach to different regions of the country and offer their products to a wider range of customers. This has led to increased availability and affordability of aesthetic medical devices in Brazil.
A few examples of strategies acquired by the key players
Similarly, recent developments related to companies in the Brazil aesthetic equipment market have been tracked by the team at Future Market Insights. These are available in the full report.
Attribute | Details |
---|---|
Historical Data Available for | 2017 to 2022 |
Forecast Period | 2023 to 2033 |
Market Analysis | US$ Million for Value and 000 Units for Volume |
Key Regions Covered | South-east Region, South Region, North-east Region, Central-west Region and North Region |
Key Countries Covered | Brazil |
Key Market Segments Covered | Device, Application, Body Parts, Social Class, End User and Region |
Key Companies Profiled |
|
Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Pricing | Available upon Request |
The high cost of aesthetic treatments is a key restraint to Brazil’s market growth.
The growth potential of the market is 15.5% through 2033.
The global market size to reach US$ 8.6 billion by 2033.
AbbVie Inc., Alma Lasers, and Cutera Inc. are the key market players.
The use of social media platforms to market aesthetic treatments.
1. Executive Summary | Brazil Aesthetic Equipment Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value Added Insights
4.1. Device Adoption Analysis/Usage Analysis
4.2. Procedure Statistics
4.3. Total Number of Aesthetic Clinics, Plastic
4.3.1.1. Surgery Clinics, Dental Clinics, Rejuvenation
4.3.1.2. Therapy Centers and Medical Spa
4.4. Regulatory Scenario
4.5. PESTLE Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Brazil GDP Growth Outlook
5.1.2. Rise in Brazil Healthcare Spending
5.2. Forecast Factors - Relevance & Impact
5.2.1. Historic Growth of Top Companies
5.2.2. Increase in the Number of Aesthetic Procedures
5.2.3. Cost of the Equipment
5.2.4. Adoption Rate
5.2.5. Growth of Cosmetic Industry in Brazil
5.2.6. Strategic Collaborations
5.2.7. New Device Launches
5.2.8. GDP Growth
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis – Impact Assessment
6.1. COVID-19 and Impact Analysis
6.1.1. Revenue By Device Type
6.1.2. Revenue By Application
6.1.3. Revenue By Body Parts
6.1.4. Revenue By Social Class
6.1.5. Revenue By End User
6.1.6. Revenue By Region
6.2. 2022 Market Scenario
7. Brazil Market Demand Volume Analysis 2017 to 2022 and Forecast, 2023 to 2033
7.1. Historical Market Volume (Units) Analysis, 2017 to 2022
7.2. Current and Future Market Volume (Units) Projections, 2023 to 2033
7.2.1. Y-o-Y Growth Trend Analysis
8. Brazil Market - Pricing Analysis
8.1. Regional Pricing Analysis By Device Type
8.2. Pricing Break Up
8.2.1. Manufacturer Level
8.2.2. Distributor Level
8.3. Brazilian Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Brazil Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033
9.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022
9.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Brazil Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Device Type
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Device Type, 2017 to 2022
10.3. Current and Future Market Size (US$ Million) and Volume(Units) Analysis and Forecast By Device Type, 2023 to 2033
10.3.1. Energy-Based Aesthetic Devices
10.3.1.1. Laser-Assisted Liposuction (LAL) Devices
10.3.1.2. Laser Resurfacing Devices
10.3.1.3. Radio Frequency-Assisted Liposuction (RFAL) Devices
10.3.1.4. Power Assisted Liposuction (PAL) Devices
10.3.1.5. Ultrasound-Assisted Liposuction (UAL) Devices
10.3.1.6. Intense Pulsed Light (IPL) Equipment
10.3.1.7. Cellulite Reduction Devices
10.3.2. Non-Energy Based Aesthetic Devices
10.3.2.1. Facial Aesthetics Products
10.3.2.1.1. Dermal Fillers
10.3.2.1.2. Botulinum Toxin Injections
10.3.2.1.3. Microderma abrasions/Chemical Peels
10.3.2.1.4. PRP (Platelet-Rich-Plasma)
10.3.2.1.5. Microneedling
10.3.2.2. Implants
10.3.2.2.1. Breast Implants
10.3.2.2.2. Buttock Implants
10.3.2.2.3. Facial Implants
10.3.2.2.4. Others Implants
10.4. Market Attractiveness Analysis By Device Type
11. Brazil Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Application
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis, By Application, 2017 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033
11.3.1. Skin Resurfacing and Tightening
11.3.2. Anti-Aging
11.3.3. Wrinkle Reduction
11.3.4. Face Lift
11.3.5. Lip Augmentation
11.3.6. Acne & Scar Treatment
11.3.7. Hair Removal
11.3.8. Body Contouring and Cellulite Reduction
11.3.9. Tattoo Removal
11.3.10. Breast Augmentation
11.3.11. Abdominoplasty
11.3.12. Lower Body Lift
11.3.13. Upper Body Lift
11.3.14. Liposuction
11.3.15. Dermabrasion
11.3.16. Dentistry
11.3.17. Others
11.4. Market Attractiveness Analysis By Application
12. Brazil Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Body Parts
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis, By Body Parts, 2017 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Body Parts, 2023 to 2033
12.3.1. Face
12.3.2. Eyes
12.3.3. Nose
12.3.4. Lip
12.3.5. Ears
12.3.6. Neck
12.3.7. Scalp
12.3.8. Body and Extremities
12.3.8.1. Arms and Elbow
12.3.8.2. Buttocks
12.3.8.3. Feet
12.3.8.4. Thigh
12.3.8.5. Breast
12.4. Market Attractiveness Analysis By Body Parts
13. Brazil Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Social Class
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Million) Analysis, By Social Class, 2017 to 2022
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Social Class, 2023 to 2033
13.3.1. Class A
13.3.2. Class B
13.3.3. Class C
13.3.4. Class D
13.4. Market Attractiveness Analysis By Social Class
14. Brazil Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by End User
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Million) Analysis, By End User, 2017 to 2022
14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033
14.3.1. Hospitals
14.3.2. Ambulatory Surgical Clinics
14.3.3. Free-Standing Aesthetic Centers
14.3.4. Dermatology & Cosmetology Clinics
14.3.5. Dental Clinics
14.3.6. Medical Spas & Wellness Centers
14.4. Market Attractiveness Analysis By End User
15. Brazil Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region
15.1. Introduction
15.2. Historical Market Size (US$ Million) Analysis By Region, 2017 to 2022
15.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033
15.3.1. Southeast region
15.3.2. South region
15.3.3. Northeast region
15.3.4. Central-west region
15.3.5. North region
15.4. Market Attractiveness Analysis By Region
16. Southeast Brazil Market 2017 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
16.3.1. By Device Type
16.3.2. By Application
16.3.3. By Body Parts
16.3.4. By Social Class
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Device Type
16.4.2. By Application
16.4.3. By Body Parts
16.4.4. By Social Class
16.4.5. By End User
16.5. Drivers and Restraints - Impact Analysis
17. South Brazil Market 2017 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
17.3.1. By Device Type
17.3.2. By Application
17.3.3. By Body Parts
17.3.4. By Social Class
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Device Type
17.4.2. By Application
17.4.3. By Body Parts
17.4.4. By Social Class
17.4.5. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
18. Northeast Brazil Market 2017 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
18.3.1. By Device Type
18.3.2. By Application
18.3.3. By Body Parts
18.3.4. By Social Class
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Device Type
18.4.2. By Application
18.4.3. By Body Parts
18.4.4. By Social Class
18.4.5. By End User
18.5. Drivers and Restraints - Impact Analysis
19. Central-West Brazil Market 2017 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
19.3. Current and Future Market Size (US$ Million) and Volume(Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
19.3.1. By Device Type
19.3.2. By Application
19.3.3. By Body Parts
19.3.4. By Social Class
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Device Type
19.4.2. By Application
19.4.3. By Body Parts
19.4.4. By Social Class
19.4.5. By End User
19.5. Drivers and Restraints - Impact Analysis
20. North Brazil Market 2017 to 2022 and Forecast 2023 to 2033
20.1. Introduction
20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
20.3.1. By Device Type
20.3.2. By Application
20.3.3. By Body Parts
20.3.4. By Social Class
20.3.5. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Device Type
20.4.2. By Application
20.4.3. By Body Parts
20.4.4. By Social Class
20.4.5. By End User
20.5. Drivers and Restraints - Impact Analysis
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
21.3.1. Regional Footprint Analysis
21.3.2. Product Footprint Analysis
21.3.3. Channel Footprint Analysis
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. AbbVie Inc. (Allergan PLC)
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Key Financials
22.3.1.4. Sales Footprint
22.3.1.5. Key Developments
22.3.1.6. SWOT Analysis
22.3.1.7. Strategy Overview
22.3.1.7.1. Marketing Strategies
22.3.1.7.2. Device Strategies
22.3.1.7.3. Channel Strategies
22.3.2. Alma Lasers
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Key Financials
22.3.2.4. Sales Footprint
22.3.2.5. Key Developments
22.3.2.6. SWOT Analysis
22.3.2.7. Strategy Overview
22.3.2.7.1. Marketing Strategies
22.3.2.7.2. Device Strategies
22.3.2.7.3. Channel Strategies
22.3.3. Cutera Inc.
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Key Financials
22.3.3.4. Sales Footprint
22.3.3.5. Key Developments
22.3.3.6. SWOT Analysis
22.3.3.7. Strategy Overview
22.3.3.7.1. Marketing Strategies
22.3.3.7.2. Device Strategies
22.3.3.7.3. Channel Strategies
22.3.4. Silimed Indústria de Implantes Ltda.
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Key Financials
22.3.4.4. Sales Footprint
22.3.4.5. Key Developments
22.3.4.6. SWOT Analysis
22.3.4.7. Strategy Overview
22.3.4.7.1. Marketing Strategies
22.3.4.7.2. Device Strategies
22.3.4.7.3. Channel Strategies
22.3.5. GC Aesthetics
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Key Financials
22.3.5.4. Sales Footprint
22.3.5.5. Key Developments
22.3.5.6. SWOT Analysis
22.3.5.7. Strategy Overview
22.3.5.7.1. Marketing Strategies
22.3.5.7.2. Device Strategies
22.3.5.7.3. Channel Strategies
22.3.6. Bausch & Lomb Incorporated
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Key Financials
22.3.6.4. Sales Footprint
22.3.6.5. Key Developments
22.3.6.6. SWOT Analysis
22.3.6.7. Strategy Overview
22.3.6.7.1. Marketing Strategies
22.3.6.7.2. Device Strategies
22.3.6.7.3. Channel Strategies
22.3.7. Hologic Inc.
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Key Financials
22.3.7.4. Sales Footprint
22.3.7.5. Key Developments
22.3.7.6. SWOT Analysis
22.3.7.7. Strategy Overview
22.3.7.7.1. Marketing Strategies
22.3.7.7.2. Device Strategies
22.3.7.7.3. Channel Strategies
22.3.8. Boston Scientific (Lumenis Inc.)
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Key Financials
22.3.8.4. Sales Footprint
22.3.8.5. Key Developments
22.3.8.6. SWOT Analysis
22.3.8.7. Strategy Overview
22.3.8.7.1. Marketing Strategies
22.3.8.7.2. Device Strategies
22.3.8.7.3. Channel Strategies
22.3.9. LUTRONIC
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Key Financials
22.3.9.4. Sales Footprint
22.3.9.5. Key Developments
22.3.9.6. SWOT Analysis
22.3.9.7. Strategy Overview
22.3.9.7.1. Marketing Strategies
22.3.9.7.2. Device Strategies
22.3.9.7.3. Channel Strategies
22.3.10. Syneron Medical Ltd
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Key Financials
22.3.10.4. Sales Footprint
22.3.10.5. Key Developments
22.3.10.6. SWOT Analysis
22.3.10.7. Strategy Overview
22.3.10.7.1. Marketing Strategies
22.3.10.7.2. Device Strategies
22.3.10.7.3. Channel Strategies
22.3.11. Venus Concept
22.3.11.1. Overview
22.3.11.2. Product Portfolio
22.3.11.3. Key Financials
22.3.11.4. Sales Footprint
22.3.11.5. Key Developments
22.3.11.6. SWOT Analysis
22.3.11.7. Strategy Overview
22.3.11.7.1. Marketing Strategies
22.3.11.7.2. Device Strategies
22.3.11.7.3. Channel Strategies
22.3.12. Genesis Biosystems, Inc.
22.3.12.1. Overview
22.3.12.2. Product Portfolio
22.3.12.3. Key Financials
22.3.12.4. Sales Footprint
22.3.12.5. Key Developments
22.3.12.6. SWOT Analysis
22.3.12.7. Strategy Overview
22.3.12.7.1. Marketing Strategies
22.3.12.7.2. Device Strategies
22.3.12.7.3. Channel Strategies
22.3.13. POLYTECH Health & Aesthetics GmbH
22.3.13.1. Overview
22.3.13.2. Product Portfolio
22.3.13.3. Key Financials
22.3.13.4. Sales Footprint
22.3.13.5. Key Developments
22.3.13.6. SWOT Analysis
22.3.13.7. Strategy Overview
22.3.13.7.1. Marketing Strategies
22.3.13.7.2. Device Strategies
22.3.13.7.3. Channel Strategies
22.3.14. Lifesil
22.3.14.1. Overview
22.3.14.2. Product Portfolio
22.3.14.3. Key Financials
22.3.14.4. Sales Footprint
22.3.14.5. Key Developments
22.3.14.6. SWOT Analysis
22.3.14.7. Strategy Overview
22.3.14.7.1. Marketing Strategies
22.3.14.7.2. Device Strategies
22.3.14.7.3. Channel Strategies
22.3.15. Candela Corp.
22.3.15.1. Overview
22.3.15.2. Product Portfolio
22.3.15.3. Key Financials
22.3.15.4. Sales Footprint
22.3.15.5. Key Developments
22.3.15.6. SWOT Analysis
22.3.15.7. Strategy Overview
22.3.15.7.1. Marketing Strategies
22.3.15.7.2. Device Strategies
22.3.15.7.3. Channel Strategies
22.3.16. Cynosure Inc
22.3.16.1. Overview
22.3.16.2. Product Portfolio
22.3.16.3. Key Financials
22.3.16.4. Sales Footprint
22.3.16.5. Key Developments
22.3.16.6. SWOT Analysis
22.3.16.7. Strategy Overview
22.3.16.7.1. Marketing Strategies
22.3.16.7.2. Device Strategies
22.3.16.7.3. Channel Strategies
22.3.17. Lumenis Ltd
22.3.17.1. Overview
22.3.17.2. Product Portfolio
22.3.17.3. Key Financials
22.3.17.4. Sales Footprint
22.3.17.5. Key Developments
22.3.17.6. SWOT Analysis
22.3.17.7. Strategy Overview
22.3.17.7.1. Marketing Strategies
22.3.17.7.2. Device Strategies
22.3.17.7.3. Channel Strategies
22.3.18. Sientra Inc
22.3.18.1. Overview
22.3.18.2. Product Portfolio
22.3.18.3. Key Financials
22.3.18.4. Sales Footprint
22.3.18.5. Key Developments
22.3.18.6. SWOT Analysis
22.3.18.7. Strategy Overview
22.3.18.7.1. Marketing Strategies
22.3.18.7.2. Device Strategies
22.3.18.7.3. Channel Strategies
22.3.19. Galderma Laboratories
22.3.19.1. Overview
22.3.19.2. Product Portfolio
22.3.19.3. Key Financials
22.3.19.4. Sales Footprint
22.3.19.5. Key Developments
22.3.19.6. SWOT Analysis
22.3.19.7. Strategy Overview
22.3.19.7.1. Marketing Strategies
22.3.19.7.2. Device Strategies
22.3.19.7.3. Channel Strategies
22.3.20. Merz Pharma
22.3.20.1. Overview
22.3.20.2. Product Portfolio
22.3.20.3. Key Financials
22.3.20.4. Sales Footprint
22.3.20.5. Key Developments
22.3.20.6. SWOT Analysis
22.3.20.7. Strategy Overview
22.3.20.7.1. Marketing Strategies
22.3.20.7.2. Device Strategies
22.3.20.7.3. Channel Strategies
22.3.21. Teoxane Laboratories
22.3.21.1. Overview
22.3.21.2. Product Portfolio
22.3.21.3. Key Financials
22.3.21.4. Sales Footprint
22.3.21.5. Key Developments
22.3.21.6. SWOT Analysis
22.3.21.7. Strategy Overview
22.3.21.7.1. Marketing Strategies
22.3.21.7.2. Device Strategies
22.3.21.7.3. Channel Strategies
22.3.22. Suneva Medical
22.3.22.1. Overview
22.3.22.2. Product Portfolio
22.3.22.3. Key Financials
22.3.22.4. Sales Footprint
22.3.22.5. Key Developments
22.3.22.6. SWOT Analysis
22.3.22.7. Strategy Overview
22.3.22.7.1. Marketing Strategies
22.3.22.7.2. Device Strategies
22.3.22.7.3. Channel Strategies
22.3.23. Anika Therapeutics
22.3.23.1. Overview
22.3.23.2. Product Portfolio
22.3.23.3. Key Financials
22.3.23.4. Sales Footprint
22.3.23.5. Key Developments
22.3.23.6. SWOT Analysis
22.3.23.7. Strategy Overview
22.3.23.7.1. Marketing Strategies
22.3.23.7.2. Device Strategies
22.3.23.7.3. Channel Strategies
23. Assumptions and Acronyms Used
24. Research Methodology
Explore Healthcare Insights
View Reports